<?xml version="1.0" encoding="UTF-8"?>
<ref id="B99-ijerph-17-01395">
 <label>99.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Head</surname>
    <given-names>M.G.</given-names>
   </name>
   <name>
    <surname>Fitchett</surname>
    <given-names>J.R.</given-names>
   </name>
   <name>
    <surname>Cooke</surname>
    <given-names>M.K.</given-names>
   </name>
   <name>
    <surname>Wurie</surname>
    <given-names>F.B.</given-names>
   </name>
   <name>
    <surname>Hayward</surname>
    <given-names>A.C.</given-names>
   </name>
   <name>
    <surname>Atun</surname>
    <given-names>R.</given-names>
   </name>
  </person-group>
  <article-title>UK investments in global infectious disease research 1997â€“2010: A case study</article-title>
  <source>Lancet Infect. Dis.</source>
  <year>2013</year>
  <volume>13</volume>
  <fpage>55</fpage>
  <lpage>64</lpage>
  <pub-id pub-id-type="doi">10.1016/S1473-3099(12)70261-X</pub-id>
  <pub-id pub-id-type="pmid">23140942</pub-id>
 </element-citation>
</ref>
